Assaf Barnea
Chief Executive Officer & Founder @ Sanara Ventures
Tel Aviv, Israel
Assaf Barnea is a seed investor at Sanara Ventures in Tel Aviv focused on Health Care and Software. Assaf Barnea, CEO of Sanara Ventures is a seasoned entrepreneur and venture professional with significant multidisciplinary experience in building innovation platforms and commercialization processes in healthcare and Cleantech. Sanara Ventures is a healthcare investment platform, jointly held by Teva Pharmaceuticals and Philips Healthcare. Assafis also a business consultant at the World Bank/IFC venture capital team, supporting the IFC’s investments in technologies that are relevant for developing countries. Formerly, Assaf was the CEO of Kinrot Ventures, the leading seed investor in water technologies worldwide. Kinrot is privately held by Hutchison water which acquired Kinrot Ventures in 2012. Assaf Barnea attended Reichman University (IDC Herzliya).
- Total investments:
- 4
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Assaf Barnea invests in
Stages Assaf Barnea invests in
Countries Assaf Barnea invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 4 (100%)
- Software 3 (75%)
- Medical Device 2 (50%)
- Artificial Intelligence 2 (50%)
- SaaS 1 (25%)
Stage
- Seed 2 (50%)
- Pre-Seed 1 (25%)
- Series A 1 (25%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| QLOG is a creator of a healthcare management platform that provides detailed visibility and control over processes and assets. The platform of the company uses the internet of things as a data-collection grid to record the process of what happened, the individual who handled it, the position of the equipment, and the recent developments of theequipment, allowing healthcare businesses to reduce the overheads and difficulties of legacy systems. | $2.5M / Seed / Jun 27, 2023 | ||
| Panacea-ml revolutionizes clinical trial design with its data-driven, explainable-AI SaaS platform. Our cutting-edge technology addresses the primary causes of clinical development failure by identifying patient profiles that maximize therapeutic efficacy, minimize safety risks, and improve participant retention. Leveraging historical clinicaltrials and millions real-world patient health records, Panacea-ml's AI model enhances patient selection criteria, reduces cohort sizes, and uncovers novel marker-endpoint interrelations, surrogate markers, and causal relationships beyond simple statistical correlations.Our platform is a game-changer for the pharmaceutical industry, facilitating seamless collaboration across drug development, data science, and clinical teams. It accelerates drug development by generating precise sub-population profiles, refining patient selection criteria, and providing informed go/no-go decisions for each phase of development. Panacea-ml is versatile, supporting small sample sizes and various therapeutic domains, including rare diseases and early development stages.At Panacea-ml, we believe in empowering innovation and fostering collaboration to drive impactful outcomes. Our mission is to shorten time to market and enable early access to innovative treatments for patients worldwide. | $1M / Pre-Seed / Nov 16, 2022 | ||
| CVAid Medical develops an innovative AI based stroke detection technological platform. | $4M / Series A / Feb 23, 2022 | ||
| Lydus Medical is a start-up company that develops a set of tools for anastomosis of small blood vessels. The company was founded in 2017 and is headquartered in Kfar Saba, Israel. | $2.7M / Seed / May 24, 2021 |
Co-Investors
About Sanara Ventures
Sanara Ventures is an innovation-investment platform, elevating outstanding healthcare-technology companies, from early-stage to global market maturity. At Sanara, They share a vision of an integrated continuum of care supported by accessible advanced healthcare solutions for people around the world.
Sanara Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Assaf Barnea
Chief Executive Officer & Founder
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Assaf Barnea invest in?
Assaf Barnea invests primarily in Health Care, Software and Medical Device startups, most often at Seed and Pre-Seed stage. Most of the 4 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Assaf Barnea?
Public channels for Assaf Barnea include LinkedIn and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Assaf Barnea last invest?
The most recent investment recorded for Assaf Barnea closed in Jun 2023. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
